pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,164 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: approval×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›COMPLETEDphase readoutNCT06054269: Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP

    Sponsor: Centers for Disease Control and Prevention. Phase: PHASE3. Conditions: Influenza

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07121283: Artificial Intelligence Assisted Bone Age Assessment

    Sponsor: Cheng-Hsin General Hospital. Phase: NA. Conditions: Bone Age

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02530983: Mayo Clinic Upper Digestive Disease Survey

    Sponsor: Mayo Clinic. Phase: . Conditions: Esophageal Neoplasms, Cancer of Esophagus, Cancer of the Esophagus, Esophageal Cancer, Esophagus Cancer, Neoplasm, Esophageal, Esophagectomy, Abnormalities, Digestive System, Digestive System Abnormalities

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04002141: Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis

    Sponsor: University of California, San Francisco. Phase: PHASE2. Conditions: Endometriosis, Ovarian Hyperstimulation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06334354: A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer Survivors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06105541: Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation

    Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Hypermobile Ehlers-Danlos Syndrome, Hypermobile Spectrum Disorder, Ehlers-Danlos Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06940141: Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

    Sponsor: Connect Biopharm LLC. Phase: PHASE2. Conditions: Asthma Acute

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07435441: Turkish Validity and Reliability of the Bolus Residue Scale in Acute Stroke

    Sponsor: Istanbul Arel University. Phase: . Conditions: Post-stroke, Dysphagia, Videofluoroscopy, Scale Reliability Validity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06997094: Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

    Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Human Papillomavirus-Negative Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma, Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma, HPV-Negative Squamous Cell Carcinoma, Resectable Head and Neck Squamous-cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06665594: Effect of TXA on Reducing Bruising After Filler Injection

    Sponsor: University of Wisconsin, Madison. Phase: PHASE2. Conditions: Facial Filler Injections, Hyaluronic Acid, Tranexamic Acid

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05687266: Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: NSCLC

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05558566: Neurofeedback From the Supplementary Motor Area for Tourette Syndrome

    Sponsor: Yale University. Phase: NA. Conditions: Tourette Syndrome in Adolescence

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01625351: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

    Sponsor: St. Jude Children's Research Hospital. Phase: PHASE1. Conditions: Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor, Hepatic Tumor, Lymphoma, Wilms Tumor, Rhabdoid Tumor, Clear Cell Carcinoma, Renal Cell Carcinoma, Melanoma, Neuroblastoma, Rhabdomyosarcoma, Non-rhabdomyosarcoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07570329: Human Milk Oligosaccharides, Gut Bifidobacterium, Vitamin D, and Infant Immunity

    Sponsor: Hasanuddin University. Phase: . Conditions: Healhty

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05203731: Level of Physical Activity and Fear Learning

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06156202: Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program for PASC Program to Improve Functioning of Persons Suffering From Post-COVID-19 Syndrome: A Randomized Controlled Trial

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: Post-Acute COVID-19, Post-Acute COVID-19 Syndrome, Post-Acute COVID-19 Infection, Long COVID, Long Covid19, Dyspnea, Orthostasis, Cognitive Impairment

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04857502: 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

    Sponsor: Jonsson Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Prostate Carcinoma, Recurrent Prostate Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04850053: Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

    Sponsor: Capital Medical University. Phase: . Conditions: Alzheimer's Disease

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03799445: Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Basaloid Carcinoma, Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Posterior Tongue Squamous Cell Carcinoma, Soft Palate Squamous Cell Carcinoma, Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Tonsillar Squamous Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06367972: A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: OligoProgressive Metastatic Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06907472: Diabetes Management for Primary Healthcare Centers.

    Sponsor: University of Abuja. Phase: NA. Conditions: Type 2 Diabetes Mellitus (T2DM)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04310995: Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts

    Sponsor: Ruijin Hospital. Phase: PHASE4. Conditions: Coronary Artery Bypass Graft, Radial Artery Grafts, Antispastic Therapy, Pilot Study

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07467395: Evaluation of Augmented Reality on Dental Pain and Anxiety During Primary Molars' Extraction

    Sponsor: Sara Hazem Mohamed Rabie. Phase: NA. Conditions: Dental Anxiety

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05841095: Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104

    Sponsor: Erasmus Medical Center. Phase: PHASE1. Conditions: Chronic Hepatitis b

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04980495: An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis

    Sponsor: argenx. Phase: PHASE3. Conditions: Generalized Myasthenia Gravis, MG - Myasthenia Gravis, gMG

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03289039: Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer

    Sponsor: Dana-Farber Cancer Institute. Phase: PHASE2. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07403539: Speech Learning and Speech Production in Parkinson's Disease

    Sponsor: State University of New York at Buffalo. Phase: NA. Conditions: Parkinson's Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06464939: Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity

    Sponsor: HysensBio Co., Ltd. Phase: PHASE2. Conditions: Dentin Hypersensitivity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07298239: An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: EARLY_PHASE1. Conditions: Prostate Cancer Castration-resistant Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06619639: Feasibility of a Social-emotional Learning Curriculum in an After-school Program for Youth

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Feasibility Studies, Efficacy of Intervention, Social Emotional Learning

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07491939: Palliative and Supportive Care to Help People With Arthritis to Live Well (ENRICH)

    Sponsor: Dorothy House Hospice. Phase: . Conditions: Inflammatory Arthritis, Palliative Care

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07198139: A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus

    Sponsor: Cocrystal Pharma, Inc.. Phase: PHASE1. Conditions: Norovirus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06510439: Need to be Needed (N2BN) Intervention

    Sponsor: Temple University. Phase: NA. Conditions: Loneliness, Social Isolation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT05897593: Clinical Feasibility & Validation of the Augmented Reality GlenxRose Acquired Brain Injury Rehabilitation Programs

    Sponsor: University of Alberta. Phase: NA. Conditions: Acquired Brain Injury, Stroke, Traumatic Brain Injury

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01150721: Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial Infection

    Sponsor: National Institutes of Health Clinical Center (CC). Phase: . Conditions: Mycobacterium Infections, Non-tuberculous

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07389421: School Meals in Denmark

    Sponsor: University of Copenhagen. Phase: NA. Conditions: Childhood Obesity, Childhood Obesity Pevention, Well-being/Quality of Life, Diet Habits, Cognitive Abilities, Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07560514: Assessment of Digital Technologies for Detection of Dental Caries

    Sponsor: University Hospital, Martin. Phase: NA. Conditions: Dental Caries

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07472816: The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo.

    Sponsor: Cairo University. Phase: PHASE4. Conditions: Vitiligo

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06812416: Effectiveness of Qualia NAD+ Supplementation on NAD Levels

    Sponsor: Qualia Life Sciences. Phase: NA. Conditions: Intracellular NAD+ Levels

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04152616: Mechanisms of Balance Disorders in a Seated Position Following a Stroke

    Sponsor: Rennes University Hospital. Phase: NA. Conditions: Stroke Sequelae

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT04848506: Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM

    Sponsor: Cytokinetics. Phase: PHASE2. Conditions: Symptomatic Hypertrophic Cardiomyopathy (HCM)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07651904: Perioperative Respiratory Adverse Events in Cleft Lip and Palate Surgery: Incidence, Risk Factors, and Clinical Scoring

    Sponsor: Marmara University Pendik Training and Research Hospital. Phase: . Conditions: Cleft Palate, Cleft Lip, Laryngospasm, Bronchospasm, Airway Obstruction, Postoperative Complications, Difficult Intubation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06177704: Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study

    Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval. Phase: . Conditions: Percutaneous Left Atrial Appendage Occlusion (LAAO), Device-related Thrombus (DRT), Thromboembolic Event, Major Cardioembolic Events, Major Bleeding - TIMI Classification

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07553104: Changes in Children and Young People's Well-being and Parental Stress While Seeking Help at CAMHS in Denmark. How Does Waiting Affect CYP and Their Parents Before, During and After CAMHS Assessments.

    Sponsor: Aalborg University Hospital. Phase: . Conditions: Mental Health Help-Seeking, Mental Health Difficulties, Help-Seeking Behavior, Waiting Times, Patient Pathways, Effect of Lifestyle-related, Clinical and Demographic Parameters on Outcomes

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT05604404: Effects of Head-of-Bed on Intracranial Pressure

    Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Subarachnoid Hemorrhage, Aneurysmal

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07521384: Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy

    Sponsor: Healing Hope International. Phase: . Conditions: Traumatic Brain Injury, Cerebral Palsy, Hypoxic Ischemic Encephalopathy, Neurologic Disorders, MS (Multiple Sclerosis), Alzheimer Dementia (AD), Parkinson Disease (PD), Stroke, Autism

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06244784: Effectiveness of an Interventional Intervention in Improving the Work Environment of Nurses and Nursing Assistants in the Hospital

    Sponsor: Universitat Internacional de Catalunya. Phase: NA. Conditions: Healthy Work Environment, Burnout, Intention to Leave, Engagement

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07313852: A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: B-cell Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukemia, Adult, B-ALL

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05528952: Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

    Sponsor: Centre Hospitalier Universitaire de Besancon. Phase: PHASE2. Conditions: Hepatocellular Carcinoma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07657052: A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria

    Sponsor: S-INFINITY Pharmaceuticals Co., Ltd. Phase: NA. Conditions: Paroxysmal Nocturnal Hemoglobinuria

    full page →ctgov ↗
    ← prev
    page 71 of 104
    next →